Not yet medically reviewed, information on this site is in preparation and has not been verified by a medical reviewer.
Drug index / Stimulant / Methylphenidate
Stimulant

Methylphenidate

methyl 2-phenyl-2-piperidin-2-ylacetate

Methylphenidate (Ritalin, Concerta) is a prescription stimulant for ADHD and narcolepsy; misuse strains the heart, can cause dependence and psychosis, and is risky combined with other drugs.

Overview

Methylphenidate is a prescription stimulant sold under brand names including Ritalin and Concerta, used to treat attention-deficit/hyperactivity disorder (ADHD) and narcolepsy. Taken as prescribed under medical supervision it can improve attention and reduce impulsivity and hyperactivity, and it is one of the most commonly prescribed ADHD medications. Like amphetamine-based stimulants, it is a controlled substance with a recognized potential for misuse, dependence, and addiction, and regulators have strengthened warnings about the serious risks of prescription stimulants. Misuse — taking more than prescribed, using it without a prescription (for example to study or stay awake), or taking it by non-oral routes — substantially raises the risks.

Source: NIDA; FDA; PubChem CID 4158

Chemistry & mechanism of action

Methylphenidate increases the activity of the neurotransmitters dopamine and norepinephrine in the brain, chiefly by blocking their reuptake so they remain active longer. This boosts alertness and attention and, at higher doses, can produce euphoria that reinforces repeated use. In people with ADHD, carefully dosed stimulant medication can improve focus and impulse control; the same mechanisms, at higher or misused doses, drive the drug's dangers — cardiovascular stimulation that raises heart rate and blood pressure, agitation, and, with heavy use, disruption of normal dopamine signaling. Repeated misuse can produce tolerance and dependence.

Source: NIDA; PubChem CID 4158

Effects

At therapeutic doses, methylphenidate improves attention and wakefulness and can reduce appetite. Common effects, especially at higher or misused doses, include increased energy and alertness, euphoria, reduced appetite, insomnia, dry mouth, headache, and a faster heartbeat. As the dose rises, effects can include anxiety, restlessness, irritability, raised blood pressure, and — at high doses or with heavy use — paranoia, hallucinations, and stimulant psychosis. Coming down can bring fatigue, low mood, and difficulty concentrating. Long-term misuse is associated with cardiovascular strain, weight loss, sleep disruption, and mental-health effects.

Source: NIDA; FDA

Risks & harms

The main acute danger is cardiovascular: methylphenidate raises heart rate and blood pressure and can, particularly at high doses or in people with underlying heart conditions, contribute to dangerously high blood pressure, irregular heart rhythms, heart attack, stroke, seizures, or dangerously high body temperature. Unlike opioids, there is no reversal medication for a stimulant overdose — emergency care is the response, so chest pain, severe agitation, very high temperature, or seizures mean calling 911. Combining methylphenidate with other stimulants (including amphetamines, cocaine, or large amounts of caffeine) compounds cardiovascular strain, and combining it with opioids or other depressants is dangerous because the stimulant can mask sedation and lead to taking more of the depressant. Heavy or high-dose use can trigger stimulant psychosis, and misuse can lead to dependence. Any pill obtained outside a licensed pharmacy can be counterfeit and may contain other substances, including fentanyl, so naloxone is worth having on hand. For poisoning guidance call Poison Control at 1-800-222-1222; for substance-use support the SAMHSA National Helpline is 1-800-662-4357.

Source: NIDA; FDA; SAMHSA

Images

Visual references coming soon.

If it’s too intense

If an experience becomes overwhelming, the goal is to stay safe and let it pass, most difficult experiences ease as the drug wears off.

  • Get to a calm, safe space with someone you trust who is sober and can stay with you.
  • Cool down if you’re overheating, move somewhere cool, remove extra layers, rest. Overheating is especially a risk with stimulants and MDMA.
  • Sip water to thirst, but don’t over-hydrate. Drinking large amounts of plain water (especially after MDMA) can dangerously dilute your blood sodium (hyponatremia). Electrolytes help more than volume.
  • Slow your breathing, long, slow exhales help settle a racing heart and anxiety.
  • A sugary drink, fruit juice, or a snack can ease shakiness and the anxiety that comes with low blood sugar.
  • Do not take more, and do not add another substance to manage it. Redosing or adding something else (including a sedative like a benzodiazepine) can make things worse, not better.

With stimulants, overheating and a racing heart are the main concerns, get somewhere cool, stop any physical activity, and don't take more.

Call 911 (or Poison Control, 1-800-222-1222) right away for chest pain, a very high body temperature, a seizure, unconsciousness, or severe confusion. These are medical emergencies, not something to wait out.

Source: general harm-reduction guidance from SAMHSA, NIH/NIDA, and MedlinePlus, in our own words. Draft, not yet medically reviewed.

Forensic dossier

Draft · every field is source-cited or marked “Unknown, pending review”

Identity

IUPAC name
methyl 2-phenyl-2-piperidin-2-ylacetatePubChem PUG-REST ↗ · retrieved 2026-06-18
SMILES
COC(=O)C(C1CCCCN1)C2=CC=CC=C2PubChem PUG-REST ↗ · retrieved 2026-06-18
InChIKey
DUGOZIWVEXMGBE-UHFFFAOYSA-NPubChem PUG-REST ↗ · retrieved 2026-06-18
Synonyms / aliases
ritalin, concerta, Methylphenidan, Phenidylate, Calocain, Plimasine, Methyl phenidylacetate, Metilfenidato, Methylphenidatum, Methyl phenidate, Daytrana, Cotempla XR-ODTPubChem PUG-REST + seed aliases ↗ · retrieved 2026-06-18

Composition

Composition
N/A — single compound (see Identity)

Physical / pill characteristics

Dosage form
3 DOSAGE FORMS AND STRENGTHS 10 mg extended-release capsules light brown opaque cap and white opaque body, imprinted TEVA on the cap and 5345 on the body 20 mg openFDA drug label ↗ · retrieved 2026-06-18
Shape
Unknown — pending review (verify tablet imprint/shape against NLM Pillbox/DailyMed; N/A if not an oral tablet)
Color
Unknown — pending review (verify tablet imprint/shape against NLM Pillbox/DailyMed; N/A if not an oral tablet)
Imprint
Unknown — pending review (verify tablet imprint/shape against NLM Pillbox/DailyMed; N/A if not an oral tablet)
Score
Unknown — pending review (verify tablet imprint/shape against NLM Pillbox/DailyMed; N/A if not an oral tablet)

Scheduling & legal status

US schedule
Unknown — pending review
International
Unknown, pending review

Effects, risks & interactions

Effects
Methylphenidate is a prescription stimulant for ADHD and narcolepsy that works by a different mechanism from the amphetamines: instead of forcing neurotransmitter release, it blocks the reuptake of dopamine and noradrenaline, raising their levels in the brain. Its felt effects are stimulant — sharper focus and attention, wakefulness, reduced hunger, and a faster, higher-pressure pulse — but the reuptake-inhibition mechanism sets it apart pharmacologically from amphetamine and the amphetamine-salt products.PubChem CID 4158 + DailyMed label ↗ · retrieved 2026-06-18
Risks
Like other stimulants, methylphenidate's chief dangers are cardiovascular: it drives pulse and blood pressure upward and, particularly with pre-existing heart disease, can bring arrhythmia, heart attack and stroke, with sudden cardiac events reported in people who have structural heart abnormalities. It can cause agitation and, at high or chronic doses, a stimulant psychosis involving new or worsened paranoia or hallucinations. It carries a potential for misuse and dependence, and commonly suppresses appetite and disturbs sleep.PubChem CID 4158 + DailyMed label ↗ · retrieved 2026-06-18
Interactions
Methylphenidate's labelling directs that it not be used with monoamine-oxidase inhibitors, or within two weeks of them, because of the hypertensive-crisis risk that stimulants pose in that combination. It also cautions that methylphenidate can reduce the effect of medicines taken to lower blood pressure, so blood pressure should be monitored and the antihypertensive dose adjusted as needed when they are used together.DailyMed §7 Drug Interactions ↗ · retrieved 2026-06-18

Pill catalog

Rx/OTC variants · openFDA + DailyMed (public domain) · draft, pending review

This drug comes in 221different versions. Make sure you’re looking at the right one, use the search above to find your exact pill by imprint, color, or shape.

Showing 24 of 221 variants

20 MG M 18
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
METHYLPHENIDATE HYDROCHLORIDE 20 mg/1
Imprint
20 MG M 1820
Color
blue
Shape
CAPSULE
Form
CAPSULE, EXTENDED RELEASE
Labeler
SpecGx LLC
Schedule
CII
NDC
0406-1820 ↗ · 2026-06-18
A902 60 mg
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
METHYLPHENIDATE HYDROCHLORIDE 60 mg/1
Imprint
A902 60 mg
Color
white
Shape
CAPSULE
Form
CAPSULE, EXTENDED RELEASE
Labeler
Actavis Pharma, Inc.
Schedule
CII
NDC
0591-3902 ↗ · 2026-06-18
FM4
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
METHYLPHENIDATE HYDROCHLORIDE 10 mg/1
Imprint
FM4
Color
white
Shape
ROUND
Form
TABLET, EXTENDED RELEASE
Labeler
Golden State Medical Supply, Inc.
Schedule
CII
NDC
51407-527 ↗ · 2026-06-18
FM5
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
METHYLPHENIDATE HYDROCHLORIDE 20 mg/1
Imprint
FM5
Color
white
Shape
ROUND
Form
TABLET, EXTENDED RELEASE
Labeler
Golden State Medical Supply, Inc.
Schedule
CII
NDC
51407-528 ↗ · 2026-06-18
TL707
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
METHYLPHENIDATE HYDROCHLORIDE 27 mg/1
Imprint
TL707
Color
gray
Shape
ROUND
Form
TABLET, EXTENDED RELEASE
Labeler
Golden State Medical Supply, Inc.
Schedule
CII
NDC
51407-925 ↗ · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
METHYLPHENIDATE HYDROCHLORIDE 20 mg/1
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
TABLET
Labeler
Bryant Ranch Prepack
Schedule
CII
NDC
72162-2087 ↗ · 2026-06-18
TL706
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
METHYLPHENIDATE HYDROCHLORIDE 18 mg/1
Imprint
TL706
Color
yellow
Shape
ROUND
Form
TABLET, EXTENDED RELEASE
Labeler
Golden State Medical Supply, Inc.
Schedule
CII
NDC
51407-924 ↗ · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
METHYLPHENIDATE HYDROCHLORIDE 10 mg/1
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
TABLET
Labeler
Bryant Ranch Prepack
Schedule
CII
NDC
72162-2086 ↗ · 2026-06-18
TL708
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
METHYLPHENIDATE HYDROCHLORIDE 36 mg/1
Imprint
TL708
Color
white
Shape
ROUND
Form
TABLET, EXTENDED RELEASE
Labeler
Golden State Medical Supply, Inc.
Schedule
CII
NDC
51407-926 ↗ · 2026-06-18
1423 M
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
METHYLPHENIDATE HYDROCHLORIDE 10 mg/1
Imprint
1423 M
Color
white
Shape
ROUND
Form
TABLET, EXTENDED RELEASE
Labeler
SpecGx LLC
Schedule
CII
NDC
0406-1445 ↗ · 2026-06-18
TL709
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
METHYLPHENIDATE HYDROCHLORIDE 54 mg/1
Imprint
TL709
Color
pink
Shape
ROUND
Form
TABLET, EXTENDED RELEASE
Labeler
Golden State Medical Supply, Inc.
Schedule
CII
NDC
51407-927 ↗ · 2026-06-18
1451 M
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
METHYLPHENIDATE HYDROCHLORIDE 20 mg/1
Imprint
1451 M
Color
white
Shape
ROUND
Form
TABLET, EXTENDED RELEASE
Labeler
SpecGx LLC
Schedule
CII
NDC
0406-1473 ↗ · 2026-06-18
72
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
METHYLPHENIDATE HYDROCHLORIDE 72 mg/1
Imprint
72
Color
blue
Shape
ROUND
Form
TABLET, EXTENDED RELEASE
Labeler
Northstar Rx LLC
Schedule
CII
NDC
72603-399 ↗ · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
METHYLPHENIDATE HYDROCHLORIDE 10 mg/1
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
TABLET, CHEWABLE
Labeler
Bryant Ranch Prepack
Schedule
CII
NDC
72162-1306 ↗ · 2026-06-18
10 MG M 18
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
METHYLPHENIDATE HYDROCHLORIDE 10 mg/1
Imprint
10 MG M 1810
Color
green
Shape
CAPSULE
Form
CAPSULE, EXTENDED RELEASE
Labeler
SpecGx LLC
Schedule
CII
NDC
0406-1810 ↗ · 2026-06-18
NP018 5
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
METHYLPHENIDATE HYDROCHLORIDE 5 mg/1
Imprint
NP018 5
Color
yellow
Shape
ROUND
Form
TABLET
Labeler
Neolpharma, Inc.
Schedule
CII
NDC
55466-101 ↗ · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
METHYLPHENIDATE HYDROCHLORIDE 36 mg/1
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
TABLET, EXTENDED RELEASE
Labeler
Bryant Ranch Prepack
Schedule
CII
NDC
72162-2394 ↗ · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
METHYLPHENIDATE HYDROCHLORIDE 27 mg/1
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
TABLET, EXTENDED RELEASE
Labeler
Bryant Ranch Prepack
Schedule
CII
NDC
72162-2395 ↗ · 2026-06-18
NP019 10
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
METHYLPHENIDATE HYDROCHLORIDE 10 mg/1
Imprint
NP019 10
Color
white
Shape
ROUND
Form
TABLET
Labeler
Neolpharma, Inc.
Schedule
CII
NDC
55466-102 ↗ · 2026-06-18
NP020 20
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
METHYLPHENIDATE HYDROCHLORIDE 20 mg/1
Imprint
NP020 20
Color
yellow
Shape
ROUND
Form
TABLET
Labeler
Neolpharma, Inc.
Schedule
CII
NDC
55466-103 ↗ · 2026-06-18
CIBA 34
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
METHYLPHENIDATE HYDROCHLORIDE 20 mg/1
Imprint
CIBA 34
Color
YELLOW
Shape
ROUND
Form
TABLET
Labeler
Sandoz Inc
Schedule
CII
NDC
66758-275 ↗ · 2026-06-18
CIBA 7
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
METHYLPHENIDATE HYDROCHLORIDE 5 mg/1
Imprint
CIBA 7
Color
YELLOW
Shape
ROUND
Form
TABLET
Labeler
Sandoz Inc
Schedule
CII
NDC
66758-273 ↗ · 2026-06-18
CIBA 3
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
METHYLPHENIDATE HYDROCHLORIDE 10 mg/1
Imprint
CIBA 3
Color
GREEN
Shape
ROUND
Form
TABLET
Labeler
Sandoz Inc
Schedule
CII
NDC
66758-274 ↗ · 2026-06-18
30 MG M 18
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
METHYLPHENIDATE HYDROCHLORIDE 30 mg/1
Imprint
30 MG M 1830
Color
red
Shape
CAPSULE
Form
CAPSULE, EXTENDED RELEASE
Labeler
SpecGx LLC
Schedule
CII
NDC
0406-1830 ↗ · 2026-06-18

Dosage

Pending medical reviewer

Sources

← Back to the drug index